| http://www.w3.org/ns/prov#value | - The Agency stated that ???with additional data to support the efficacy and safety of eteplirsen for the treatment of DMD, an NDA should be fileable,??? and outlined examples of additional data and analysis that, if positive, will be important to enhance the acceptability of an NDA filing by addressing areas of ongoing concern in the existing dataset.
|
